Peter J. Demaria

About Peter J. Demaria

Peter J. DeMaria, MD is a medical oncologist and Senior Clinical Investigator who specializes in early phase drug development at NEXT Oncology. Dr. DeMaria is a graduate of the NCI-FDA Interagency Oncology Task Force, a joint fellowship program with the National Cancer Institute (NCI), National Institutes of Health (NIH), and the U.S. Food and Drug Administration (FDA). Dr. DeMaria completed an NCI-sponsored combined clinical fellowship in hematology and oncology through the NIH Intramural Research Program. He later served as a medical officer with the Office of Oncologic Diseases, Office of New Drugs, Center for Drug Evaluation and Research, FDA. Prior to joining the federal government, he completed residency training in internal medicine and a clinical fellowship in hospice and palliative medicine at Jackson Memorial Hospital. He received his medical degree from the University of Miami Miller School of Medicine and his undergraduate degree in economics from Dartmouth College. With a focus on the development of novel cancer therapies, Dr. DeMaria’s skillset includes clinical trial methodology and analysis, clinical aspects of medical product development, and regulation to facilitate the movement of drugs, biologics, and devices from the basic bench science to commercialization. Dr. DeMaria is certified by the American Board of Internal Medicine in medical oncology, internal medicine, and hospice & palliative medicine. He is board eligible in hematology. Active licensure in Texas and Florida.

Experience

1. Medical Oncologist

   Texas Oncology

   Sep 2024 — Present · Houston, TX, US

   Credentialed at- Texas Oncology, PA (Houston, TX)- Houston Methodist Hospital (Houston, TX)- Baylor St. Luke’s Medical Center (Houston, TX)- HCA Women’s Hospital of Texas (Houston, TX)

Education

• Dartmouth College

  A.B., Economics

• University of Miami Miller School of Medicine

  Doctor of Medicine (MD)